Random or rational design? Evaluation of diverse compound subsets from chemical structure databases

Journal of Medicinal Chemistry

Volumn 41, Issue 4, 1998, Pages 478-488

  Pötter, Thorsten ^a   Matter, Hans ^b,c  

^a BAYER AG   (Germany)

^b Tripos GmbH   (Germany)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOUND;

ARTICLE; CHEMICAL STRUCTURE; CLUSTER ANALYSIS; CONTROLLED STUDY; DATA BASE; DRUG DESIGN; METHODOLOGY; PROBABILITY; RANDOMIZATION; STRUCTURE ACTIVITY RELATION;

DATABASES; DRUG DESIGN; MODELS, MOLECULAR; PROBABILITY; REPRODUCIBILITY OF RESULTS; SOFTWARE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032509984     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9700878     Document Type: Article

References (40)

1. Molecular Similarity in Drug Design; Dean, P. M., Ed.; Chapman and Hall: London, 1995.
2. For recent reviews, see: (a) Gallop, M. A.;Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gordon, E. M. Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries. J. Med. Chem. 1994, 37, 1233-1251. (b) Gordon, E. M.; Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gallop, M. A. Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies, and Future Directions. J. Med. Chem. 1994, 37, 1385-1399. (c) Madden, D.; Krchnak, V.; Lebl, M. Synthetic Combinatorial Libraries; Views on Techniques and Their Applications. Persp. Drug Discovery Des. 1995, 2, 269-285. (d) Ellman, J. A. Design, Synthesis and Evaluation of Small-Molecule Libraries. Acc. Chem. Res. 1996, 29, 132-143. (e) Gordon, E. M.; Gallop, M. A.; Patel, D. V. Strategy and Tactics in Combinatorial Organic Synthesis. Application to Drug Discovery. Acc. Chem. Res. 1996, 29, 144-154.
3. For recent reviews, see: (a) Gallop, M. A.;Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gordon, E. M. Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries. J. Med. Chem. 1994, 37, 1233-1251. (b) Gordon, E. M.; Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gallop, M. A. Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies, and Future Directions. J. Med. Chem. 1994, 37, 1385-1399. (c) Madden, D.; Krchnak, V.; Lebl, M. Synthetic Combinatorial Libraries; Views on Techniques and Their Applications. Persp. Drug Discovery Des. 1995, 2, 269-285. (d) Ellman, J. A. Design, Synthesis and Evaluation of Small-Molecule Libraries. Acc. Chem. Res. 1996, 29, 132-143. (e) Gordon, E. M.; Gallop, M. A.; Patel, D. V. Strategy and Tactics in Combinatorial Organic Synthesis. Application to Drug Discovery. Acc. Chem. Res. 1996, 29, 144-154.
4. For recent reviews, see: (a) Gallop, M. A.;Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gordon, E. M. Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries. J. Med. Chem. 1994, 37, 1233-1251. (b) Gordon, E. M.; Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gallop, M. A. Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies, and Future Directions. J. Med. Chem. 1994, 37, 1385-1399. (c) Madden, D.; Krchnak, V.; Lebl, M. Synthetic Combinatorial Libraries; Views on Techniques and Their Applications. Persp. Drug Discovery Des. 1995, 2, 269-285. (d) Ellman, J. A. Design, Synthesis and Evaluation of Small-Molecule Libraries. Acc. Chem. Res. 1996, 29, 132-143. (e) Gordon, E. M.; Gallop, M. A.; Patel, D. V. Strategy and Tactics in Combinatorial Organic Synthesis. Application to Drug Discovery. Acc. Chem. Res. 1996, 29, 144-154.
5. For recent reviews, see: (a) Gallop, M. A.;Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gordon, E. M. Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries. J. Med. Chem. 1994, 37, 1233-1251. (b) Gordon, E. M.; Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gallop, M. A. Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies, and Future Directions. J. Med. Chem. 1994, 37, 1385-1399. (c) Madden, D.; Krchnak, V.; Lebl, M. Synthetic Combinatorial Libraries; Views on Techniques and Their Applications. Persp. Drug Discovery Des. 1995, 2, 269-285. (d) Ellman, J. A. Design, Synthesis and Evaluation of Small-Molecule Libraries. Acc. Chem. Res. 1996, 29, 132-143. (e) Gordon, E. M.; Gallop, M. A.; Patel, D. V. Strategy and Tactics in Combinatorial Organic Synthesis. Application to Drug Discovery. Acc. Chem. Res. 1996, 29, 144-154.
6. For recent reviews, see: (a) Gallop, M. A.;Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gordon, E. M. Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries. J. Med. Chem. 1994, 37, 1233-1251. (b) Gordon, E. M.; Barrett, R. W.; Dower, W. J.; Fodor, S. P. A.; Gallop, M. A. Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies, and Future Directions. J. Med. Chem. 1994, 37, 1385-1399. (c) Madden, D.; Krchnak, V.; Lebl, M. Synthetic Combinatorial Libraries; Views on Techniques and Their Applications. Persp. Drug Discovery Des. 1995, 2, 269-285. (d) Ellman, J. A. Design, Synthesis and Evaluation of Small-Molecule Libraries. Acc. Chem. Res. 1996, 29, 132-143. (e) Gordon, E. M.; Gallop, M. A.; Patel, D. V. Strategy and Tactics in Combinatorial Organic Synthesis. Application to Drug Discovery. Acc. Chem. Res. 1996, 29, 144-154.
7. Ferguson, A. M.; Patterson, D. E.; Garr, C.; Underiner, T. Designing Chemical Libraries for Lead Discovery. J. Biomol. Screen. 1996, 7,65-73.
8. Moos, W. H.; Green, G. D.; Pavia, M. R. Recent Advances in the Generation of Molecular Diversity. Annu. Rep. Med. Chem. 1993, 28, 315-324.
9. Martin, E. J.; Blaney, J. M.; Siani, M. A.; Spellmeyer, D. C.; Wong, A. K.; Moos, W. H. Measuring Diversity; Experimental Design of Combinatorial Libraries for Drug Discovery. J. Med. Chem. 1995, 38, 1431-1436.
10. Maggiora, G. M.; Johnson, M. A. Concepts and Applications of Molecular Similarity, John Wiley & Sons: New York, 1990; pp 99-117.
11. (a) Patterson, D. E.; Cramer, R. D., III; Ferguson, A. M.; Clark, R. D.; Weinberger, L. E. Neighborhood Behavior: A Useful Concept for Validation of Molecular Diversity Descriptors. J. Med. Chem. 1996, 39, 3049-3059.
12. (b) Brown, R. D.; Bures, M. G.; Martin, Y. C. Similarity and Cluster Analysis Applied to Molecular Diversity. Presented at the American Chemical Society Meeting, Anaheim, CA, 1995; COMP3.
13. (c) Brown, R. D.; Martin, Y. C. Use of Structure-Activity Data to Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection. J. Chem. Inf. Comput. Sci. 1996, 36, 572-684.
14. (d) Matter, H. Selecting Optimally Diverse Compounds from Structure Databases: A Validation Study of 2D and 3D Molecular Descriptors. J. Med. Chem. 1997, 40, 1219-1229.
15. Young, S. S.; Farmen, M.; Rusinko, A., III. Random Versus Rational. Which is Better for General Compound Screening? Network Sci. (electronic publication) 1996, 2.
16. DePriest, S. A.; Mayer, D.; Naylor, C. B.; Marshall, G. R. 3D-QSAR of Angiotensin-Converting Enzyme and Thermolysin Inhibitors: A Comparison of CoMFA Models Based on Deduced and Experimentally Determined Active Site Geometries. J. Am. Chem. Soc. 1993, 115, 5372-5384.
17. (a) Willett, P. Similarity and Clustering in Chemical Information Systems; Letchworth: Research Studies Press, 1987.
18. (b) Willett, P.; Winterman, V. A. Comparison of Some Measures for the Determination of Intermolecular Structural Similarity. Quant. Struct.-Act. Relat. 1986, 5, 18-25.
19. Matter, H.; Lassen, D. Compound Libraries for Lead Discovery. Chim. Oggi 1996, 14 (6), 9-15.
20. SYBYL Molecular Modelling Package, versions 6.22 and 6.25; Tripos Inc., 1699 S. Hanley Rd., St. Louis, MO 63144.
21. UNITY Chemical Information Software, version 2.5; Tripos Inc., 1699 S. Hanley Rd., St. Louis, MO 63144.
22. For details and setup files to compute fingerprints, see: UNITY Chemical Information Software, version 2.5, Reference Guide; Tripos Inc.; St. Louis, MO; pp 45-58.
23. Holliday, J. D.; Ranade, S. S.; Willett, P. A Fast Algorithm for Selecting Sets of Dissimilar Molecules from Large Chemical Databases. QSAR 1996, 14, 501-506.
24. Lajiness, M.; Johnson, M. A.; Maggiora, G. M. Implementing Drug Screening Programs using Molecular Similarity Methods. In QSAR: Quantitative Structure-Activity Relationships in Drug Design; Fauchere, J. L., Ed.; Alan R. Liss Inc.: New York, 1989; pp 173-176.
25. Taylor, R. Simulation Analysis of Experimental Design Strategies for Screening Random Compounds as Potential New Drugs and Agrochemicals. J. Chem. Inf. Comput. Sci. 1995, 35, 59-67.
26. Barnard, J. M.; Downs, G. M. Clustering of Chemical Structures on the Basis of Two-Dimensional Similarity Measures. J. Chem. Inf. Comput. Sci. 1992, 32, 644-649.
27. SYBYL 6.2, Ligand-Based Design Manual; Tripos, Inc.: St. Louis, MO, 1995; pp 246-255 and references therein.
28. Cramer, R. D., III; Patterson, D. E.; Bunce, J. E. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
29. Clark, M.; Cramer, R. D., III; Jones, D. M.; Patterson, D. E.; Simeroth, P. E. Comparative Molecular Field Analysis (CoMFA). 2. Towards Its Use with 3D-Structural Databases. Tetrahedron Comput. Methodol, 1990, 3, 47-59.
30. 3D-QSAR in Drug Design. Theory, Methods and Applications; Kubinyi, H., Ed.; ESCOM: Leiden, The Netherlands, 1993. This includes many applications and cross-references of the CoMFA methodology in medicinal chemistry.
31. (a) Thibaut, U.; Folkers, G.; Klebe, G.; Kubinyi, H.; Merz, A.; Rognan, D. Recommendations for CoMFA Studies and 3D QSAR Publications. In 3D QSAR in Drug Design. Theory, Methods and Applications-, Kubinyi, H., Ed.; ESCOM: Leiden, The Netherlands, 1993; pp 711-717.
32. (b) Folkers, G.; Merz, A.; Rognan, D. CoMFA: Scope and Limitations. Ibid. pp 583-616.
33. (c) Cramer, R. D., III; DePriest, S. A.; Patterson, D. E.; Hecht, P. The Developing Practice of Comparative Molecular Field Analysis. Ibid. pp 443-485.
34. Sheridan, R. P.; Nachbar, R. B.; Bush, B. L. Extending the Trend Vector: The Trend Matrix and Sample-Based Partial Least Squares. J. Comput.-Aided Mol. Des. 1994, 8, 323-340.
35. Index Chemical Database - subset from 1993; Institute for ' Scientific Information, Inc. (ISI), 3501 Market St., Philadelphia, PA.
36. Carpignano, R.; Dolci, M.; Scarfi, D. Design of More Informative Molecules for QSAR Study in a Series of Juvenile Hormones. In Trends in QSAR Molecular Modelling 92, Proceedings of the European Symposium on Structure-Activity Relationships; Wermuth, C.-G., Ed.; ESCOM: Leiden, The Netherlands, 1993.
37. (a) Norinder, U.; Hoegberg, T. PLS-Based Quantitative Structure-Activity Relationship for Substituted Benzamides of Clebopride Type. Application of Experimental Design in Drug Research. Acta Chem. Scand. 1992,46, 363-366.
38. (b) Norinder, U. Experimental Design-Based Quantitative Structure-Toxicity Relationship of Some Local Anesthetics Using the PLS Method.. J. Appl. Toxicol. 1992, 12, 143-147.
39. (c) Norinder, U. An Experimental Design Based Quantitative Structure-Activity Relationship Study on β-Adrenergic Blocking Agents Using PLS. Drug. Des. Discovery 1991, 8, 127-136. (d) Norinder, U. Experimental Design Based 3D QSAR Analysis of Steroid-Protein Interaction: Application to Human CBG Complexes. J. Comput.-Aided I. Mol. Des. 1990, 4, 381-389.
40. (c) Norinder, U. An Experimental Design Based Quantitative Structure-Activity Relationship Study on β-Adrenergic Blocking Agents Using PLS. Drug. Des. Discovery 1991, 8, 127-136. (d) Norinder, U. Experimental Design Based 3D QSAR Analysis of Steroid-Protein Interaction: Application to Human CBG Complexes. J. Comput.-Aided I. Mol. Des. 1990, 4, 381-389.